Chenglong Liu

4PUBLICATIONS
8CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 12, 2023
Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2-Induced Inflammation.

Fan Yang, Chenglong Liu, Pengyuan Li

|Jan 11, 2023
Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the β-Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the Treatment of Colorectal Cancer.

Hao Zhang, Chenglong Liu, Qiushi Chen

|Dec 30, 2022
Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin's Interactions with Its Nuclear Partners.

Hao Zhang, Chenglong Liu, Di Zhu

|Apr 12, 2022
IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment.

Bo Hu, Mincheng Yu, Xiaolu Ma

Pageof 1

Frequent Collaborators

2 joint publications

Hao Zhang

1 joint publications

Jialei Sun

1 joint publications

Peiyao Fu

1 joint publications

Yungang He